Journal of Pediatric Neurology 2020; 18(02): 103-105
DOI: 10.1055/s-0039-1677711
Case Report
Georg Thieme Verlag KG Stuttgart · New York

Atypical Subacute Sclerosing Panencephalitis in a Young Child: Implications for Change in Vaccination Strategy

Chandrika Azad
1   Department of Pediatrics, Government Medical College and Hospital, Chandigarh, India
,
Adhi Arya
1   Department of Pediatrics, Government Medical College and Hospital, Chandigarh, India
,
Deepti Raina
2   Government Institute for Rehabilitation of Intellectual Disabilities, Chandigarh, India
,
Rekha Gupta
3   Department of Radiodiagnosis, Government Medical College and Hospital, Chandigarh, India
› Author Affiliations
Further Information

Publication History

16 October 2018

18 December 2018

Publication Date:
21 January 2019 (online)

Abstract

Subacute sclerosing panencephalitis (SSPE) is a serious neurological complication of measles with no satisfactory treatment options. The prolonged incubation period makes it rare in young children. The occurrence of primary measles infection in infants before age of vaccination can be prevented only by ensuring adequate vaccination of all females in childbearing age. Here, we present a case of an atypical presentation of SSPE in a toddler who contracted measles at 6 months of age.

 
  • References

  • 1 Buchanan R, Bonthius DJ. Measles virus and associated central nervous system sequelae. Semin Pediatr Neurol 2012; 19 (03) 107-114
  • 2 Campbell H, Andrews N, Brown KE, Miller E. Review of the effect of measles vaccination on the epidemiology of SSPE. Int J Epidemiol 2007; 36 (06) 1334-1348
  • 3 Dyken PR. Subacute sclerosing panencephalitis. Current status. Neurol Clin 1985; 3 (01) 179-196
  • 4 Erturk O, Karslıgil B, Cokar O. , et al. Challenges in diagnosing SSPE. Childs Nerv Syst 2011; 27 (12) 2041-2044
  • 5 Garg RK. Subacute sclerosing panencephalitis. J Neurol 2008; 255 (12) 1861-1871
  • 6 Saurabh K, Gupta R, Khare S, Sharma S. Atypical subacute sclerosing panencephalitis with short onset latency. Indian Pediatr 2013; 50 (02) 244-245
  • 7 Simşek E, Oztürk A, Yavuz C, Kocabay K. Subacute sclerosing panencephalitis (SSPE) associated with congenital measles infection. Turk J Pediatr 2005; 47 (01) 58-62
  • 8 Aulakh R, Tiwari A. Subacute sclerosing panencephalitis in a toddler: changing epidemiological trends. Case Rep Pediatr 2013; 2013: 341462
  • 9 Dasopoulou M, Covanis A. Subacute sclerosing panencephalitis after intrauterine infection. Acta Paediatr 2004; 93 (09) 1251-1253
  • 10 Cáceres VM, Strebel PM, Sutter RW. Factors determining prevalence of maternal antibody to measles virus throughout infancy: a review. Clin Infect Dis 2000; 31 (01) 110-119
  • 11 Maldonado YA, Lawrence EC, DeHovitz R, Hartzell H, Albrecht P. Early loss of passive measles antibody in infants of mothers with vaccine-induced immunity. Pediatrics 1995; 96 (3 Pt 1): 447-450
  • 12 Aaby P, Martins CL, Ravn H, Rodrigues A, Whittle HC, Benn CS. Is early measles vaccination better than later measles vaccination?. Trans R Soc Trop Med Hyg 2015; 109 (01) 16-28
  • 13 Hansen JS, Thysen SM, Rodrigues A, Martins C, Fisker AB. Is early measles vaccination associated with stronger survival benefits than later measles vaccination?. BMC Public Health 2018; 18 (01) 984
  • 14 Fowlkes AL, Witte D, Beeler J. , et al. Supplemental measles vaccine antibody response among HIV-infected and -uninfected children in Malawi after 1- and 2-dose primary measles vaccination schedules. Vaccine 2016; 34 (12) 1459-1464
  • 15 Smetana J, Chlibek R, Hanovcova I. , et al. Decreasing seroprevalence of measles antibodies after vaccination - possible gap in measles protection in adults in the Czech Republic. PLoS One 2017; 12 (01) e0170257
  • 16 Shrivastava SR, Shrivastava PS, Ramasamy J. 2017 Measles-rubella vaccination campaign in India. Int J Prev Med 2018; 9: 31